The importance of tumour necrosis factor-alpha (TNF-α) in the human immune response to Borrelia burgdorferi is uncertain. Murine models suggest a critical role, including spirochaete reactivation following TNF-α inhibition. Our case, combined with a review of the clinical and scientific literature, provides reassurance that TNF-α inhibition can be safely reinstituted after treatment of disseminated borreliosis with standard duration antimicrobial chemotherapy.
DefosseDL, JohnsonRC. In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect Immun1992; 60: 1109–13.
5.
GlicksteinL, MooreB, BledsoeT. Inflammatory cytokine production predominates in early Lyme disease in patients with erythema migrans. Infect Immun2003; 71: 6051–3.
6.
SjowallJ, CarlssonA, VaaralaO. Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-alpha and interleukin-12 in asymptomatic individuals in response to live spirochetes. Clin Exp Immunol2005; 141: 89–98.
7.
WidheM, GrusellM, EkerfeltC. Cytokines in Lyme borreliosis: lack of early tumour necrosis factor-α and transforming growth factor-α(1) responses are associated with chronic neuroborreliosis. Immunology2002; 107: 46–55.
8.
MulleggerRR, McHughG, RuthazerR. Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans. J Invest Dermatol2000; 115: 1115–23.
9.
MarquesA, SchwartzI, WormserGP. Transcriptome assessment of erythema migrans skin lesions in patients with early Lyme disease reveals predominant interferon signalling. J Infect Dis2017; 217: 158–67.
10.
SteereA, AngelisS. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum2006; 54: 3079–86.
11.
BonnetN, GuisS, DrancourtM. Borreliosis in a patient treated with anti-TNF alpha therapy: first case. J Eur Acad Dermatol Venereol2011; 25: 367–8.
12.
MerkakMI, TomazicJ, StrleF. Lyme neuroborreliosis in a patient treated with TNF-alpha inhibitor. Infection2015; 43: 759–62.
